Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
28 hedge funds and large institutions have $11.7M invested in Alexza Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
34% more capital invested
Capital invested by funds: $8.74M → $11.7M (+$2.99M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 31 → 28 (-3)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$108K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$69.8K |
| 3 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$22.6K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$6.43K |
| 5 |
MA
MUFG Americas
New York
|
+$1.99K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$401K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$72.4K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$33K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$31K |
| 5 |
Morgan Stanley
New York
|
-$16.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$72.4K | -35,258 | Closed |
|
|
VKH
27
Virtu KCG Holdings
New York
| – | -$33K | -22,449 | Closed |
|
|
28
Group One Trading
Chicago,
Illinois
| – | -$31K | -20,875 | Closed |
|
29
Citigroup
New York
| – | -$1K | -957 | Closed |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | -$158 | -77 | -25% |
|
ALXA Hedge Fund Activity: Q1 2015 in Review
28 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q1 2015, worth a combined $11.7M — up 34% from $8.74M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ALXA and 1 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $108K. The largest seller was Royal Bank of Canada, cutting an estimated $401K.
- 28 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q1 2015, down from 31 in Q4 2014.
- Funds reported $11.7M of Alexza Pharmaceuticals Inc stock for Q1 2015, up 34% quarter-over-quarter.
- 1 fund opened new Alexza Pharmaceuticals Inc positions in Q1 2015 and 4 closed out, a net change of -3 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q1 2015 was Jacobs Levy Equity Management, an estimated $108K added.
- The largest Alexza Pharmaceuticals Inc seller in Q1 2015 was Royal Bank of Canada, an estimated $401K sold.
Based on aggregated 13F filings for Q1 2015.